Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.

ClinicalTrials.gov ID: NCT06579105

Public ClinicalTrials.gov record NCT06579105. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb, Randomized, Double-blind, Placebo-controlled and Open-label Active Comparator Study to Evaluate the Efficacy, Safety, and Tolerability of AZD5004 in Adults With Type 2 Diabetes Mellitus.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase IIb, randomised, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes mellitus, compared to placebo and active comparator.

Study identification

NCT ID
NCT06579105
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
406 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 7, 2024
Primary completion
Dec 18, 2025
Completion
Dec 18, 2025
Last update posted
Jan 12, 2026

2024 – 2025

United States locations

U.S. sites
50
U.S. states
29
U.S. cities
50
Facility City State ZIP Site status
Research Site Mobile Alabama 36608
Research Site Sheffield Alabama 35660
Research Site Vestavia Hills Alabama 35216
Research Site Tucson Arizona 85710
Research Site Little Rock Arkansas 72205
Research Site Long Beach California 90815
Research Site Los Angeles California 90017
Research Site Newport Beach California 92660
Research Site Sacramento California 95821
Research Site Waterbury Connecticut 06708
Research Site Lake City Florida 32055
Research Site Largo Florida 33777
Research Site Ocoee Florida 34761
Research Site Orlando Florida 32804
Research Site Decatur Georgia 30030
Research Site Savannah Georgia 31406
Research Site Lombard Illinois 60148
Research Site Potomac Maryland 20854
Research Site Boston Massachusetts 02115
Research Site Roslindale Massachusetts 02131
Research Site Farmington Hills Michigan 48334
Research Site Gulfport Mississippi 39503
Research Site Kansas City Missouri 64111
Research Site Omaha Nebraska 68134
Research Site Las Vegas Nevada 89109
Research Site Albuquerque New Mexico 87107
Research Site Binghamton New York 13905
Research Site Durham North Carolina 27701
Research Site Greensboro North Carolina 27408
Research Site Rocky Mount North Carolina 27804
Research Site Statesville North Carolina 28625
Research Site Wilmington North Carolina 28401
Research Site Winston-Salem North Carolina 27103
Research Site Fargo North Dakota 58104
Research Site Beachwood Ohio 44122
Research Site Cincinnati Ohio 45219
Research Site Medford Oregon 97504
Research Site West Chester Pennsylvania 19380
Research Site Gaffney South Carolina 29340
Research Site Bristol Tennessee 37620
Research Site Abilene Texas 79606
Research Site Dallas Texas 75230
Research Site El Paso Texas 79935
Research Site Houston Texas 77004
Research Site West Jordan Utah 84088
Research Site Charlottesville Virginia 22911
Research Site Manassas Virginia 20110
Research Site Norfolk Virginia 23504
Research Site Seattle Washington 98105
Research Site Kingwood West Virginia 26537

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06579105, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06579105 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →